7 research outputs found

    Evaluating the feasibility of using the red mason bee (Osmia bicornis L.) in different experimental setups

    Get PDF
    Background: Evaluating hazards of pesticides to beneficial insects has become very important for the assessment and registration of pesticides. Test methods for honeybees are well established in the laboratory, under semi-field and field conditions. However, experiences in using other pollinators as model species are limited. Here we present results of various experiments on the red mason bee (Osmia bicornis L.), a solitary, commercially used bee species. The aim was to compare methodologies, to assess test parameters, and to evaluate the feasibility of using O. bicornis in late season, when this bee species would have already finished its life cycle under natural conditions. Results: Hatching times and hatching rates varied depending on temperature and season. Provisioning and reproduction of O. bicornis were very variable, weather-dependent and not always reliably reproducible between seasons. They were higher in early than in late season in the field. In late season cardboard tubes showed greater cell production than wooden boards. Conclusion: O. bicornis is a good study system under semi-field and field conditions: cocoons are easy to handle, and to monitor. Since hatching rate and cell production decreased over time, experiments are most recommended in early to mid season. Cardboard tubes can be used as standardised, inexpensive nesting devices. However, they do not allow continuous observation and pollen sampling, and involve time-consuming handling in the laboratory. Our experiment on nest material was conducted in late season and may not mirror conditions in spring and early summer.Keywords: solitary bees, field experiments, semi-field experiments, reproduction, hatching, nestin

    3.13 Tank mixtures of insecticides and fungicides, adjuvants, additives, fertilizers and their effects on honey bees after contact exposure in a spray chamber

    Get PDF
    In agriculture honey bees may be exposed to multiple pesticides. In contrast to single applications of plant protection products (PPP), the effects of tank mixtures of two or more PPP on honey bees are not routinely assessed in the risk assessment of plant protection products. However, tank mixes are often common practice by farmers. Mixtures of practically non-toxic substances can lead to synergistic increase of toxic effects on honey bees, observed for the first time in 19921 in combinations of pyrethroids and azole fungicides. 2004 Iwasa et al. already reported that ergosterol-biosynthesis-inhibiting (EBI) fungicides strongly increase the toxicity of neonicotinoids in laboratory for the contact exposure route. Furthermore, in agricultural practice additives, adjuvants and fertilizers may be added to the spray solution. For these additives usually no informations on potential side effects on bees are available when mixed with plant protection products. Therefore, it is considered necessary to investigate possible additive or synergistic impacts and evaluate potentially critical combinations to ensure protection of bees. Here, we investigated the effects on bees of combinations of insecticides, fungicides and fertilizers under controlled laboratory conditions. A spray chamber was used to evaluate effects following contact exposure by typical field application rates. Subsequently, mortality and behaviour of bees were monitored for at least 48 h following the OECD acute contact toxicity test 2143. Dependencies of synergistic effects and the time intervals between the applications of the mixing partners were evaluated.In agriculture honey bees may be exposed to multiple pesticides. In contrast to single applications of plant protection products (PPP), the effects of tank mixtures of two or more PPP on honey bees are not routinely assessed in the risk assessment of plant protection products. However, tank mixes are often common practice by farmers. Mixtures of practically non-toxic substances can lead to synergistic increase of toxic effects on honey bees, observed for the first time in 19921 in combinations of pyrethroids and azole fungicides. 2004 Iwasa et al. already reported that ergosterol-biosynthesis-inhibiting (EBI) fungicides strongly increase the toxicity of neonicotinoids in laboratory for the contact exposure route. Furthermore, in agricultural practice additives, adjuvants and fertilizers may be added to the spray solution. For these additives usually no informations on potential side effects on bees are available when mixed with plant protection products. Therefore, it is considered necessary to investigate possible additive or synergistic impacts and evaluate potentially critical combinations to ensure protection of bees. Here, we investigated the effects on bees of combinations of insecticides, fungicides and fertilizers under controlled laboratory conditions. A spray chamber was used to evaluate effects following contact exposure by typical field application rates. Subsequently, mortality and behaviour of bees were monitored for at least 48 h following the OECD acute contact toxicity test 2143. Dependencies of synergistic effects and the time intervals between the applications of the mixing partners were evaluated

    Neonicotinoids and bees: A large scale field study investigating residues and effects on honeybees, bumblebees and solitary bees in oilseed rape grown from clothianidin-treated seed

    Get PDF
    In 2013, the European Food Safety Authority (EFSA) has highlighted several data gaps regarding the exposure and risk of pesticides to honeybees, bumblebees and solitary bees, including the risks from exposure to contaminated nectar and pollen. This study aims to contribute data, results and conclusions to obtain more information on exposure and risks of flowering oilseed rape seed treated with the neonicotinoid clothianidin, to pollinators. Semi-field and field trials were conducted at five different locations across Germany, using the Western honeybee (Apis mellifera L.), the buff-tailed bumblebee (Bombus terrestris L.) and the red mason bee (Osmia bicornis L.) as study organisms.Highest amounts of clothianidin residues were measured in single samples of mud cell walls (7.2 μg kg-1) and pollen (5.9 μg kg-1) from solitary bee nests. Residues in nectar from honey sacs, honeybee combs and bumblebee nests (2.2, 2.9, and 3.0 μg kg-1 respectively) showed no clear differences in the amount of residues, neither did residues in pollen (1.5, 1.8, and 1.3 μg kg-1 respectively). These results suggest differences in the risk profiles of those three bee species. Keywords: clothianidin, residues, honeybees, bumblebees, solitary bees, field, semi-fiel

    The normal intestinal mucosa: a state of ‘controlled inflammation’

    No full text

    The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

    Get PDF
    Background: Venous thromboembolism (VTE) is a major health problem, with over one million events every year in Europe. However, there is a paucity of data on the current management in real life, including factors influencing treatment pathways, patient satisfaction, quality of life (QoL), and utilization of health care resources and the corresponding costs. The PREFER in VTE registry has been designed to address this and to understand medical care and needs as well as potential gaps for improvement. Methods/design: The PREFER in VTE registry was a prospective, observational, multicenter study conducted in seven European countries including Austria, France Germany, Italy, Spain, Switzerland, and the UK to assess the characteristics and the management of patients with VTE, the use of health care resources, and to provide data to estimate the costs for 12 months treatment following a first-time and/or recurrent VTE diagnosed in hospitals or specialized or primary care centers. In addition, existing anticoagulant treatment patterns, patient pathways, clinical outcomes, treatment satisfaction, and health related QoL were documented. The centers were chosen to reflect the care environment in which patients with VTE are managed in each of the participating countries. Patients were eligible to be enrolled into the registry if they were at least 18 years old, had a symptomatic, objectively confirmed first time or recurrent acute VTE defined as either distal or proximal deep vein thrombosis, pulmonary embolism or both. After the baseline visit at the time of the acute VTE event, further follow-up documentations occurred at 1, 3, 6 and 12 months. Follow-up data was collected by either routinely scheduled visits or by telephone calls. Results: Overall, 381 centers participated, which enrolled 3,545 patients during an observational period of 1 year. Conclusion: The PREFER in VTE registry will provide valuable insights into the characteristics of patients with VTE and their acute and mid-term management, as well as into drug utilization and the use of health care resources in acute first-time and/or recurrent VTE across Europe in clinical practice. Trial registration: Registered in DRKS register, ID number: DRKS0000479
    corecore